Clinical Trial Update: Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating low-dose thrombolysis, ultrasound-assisted thrombolysis, and heparin for intermediate-high risk pulmonary embolism is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Drugs mentioned

• Alteplase (alteplase)
• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Pulmonary Embolism | Phase 3 | Status: ACTIVE_NOT_RECRUITING